Poxel - Pharmaceutical Company set-up to find innovative solutions for metabolic diseases management with a primary focus on type 2 diabetes

Scientific Advisory Board

Poxel receives guidance from a distinguished Scientific Advisory Board composed of prominent scientists in the fields of diabetes, metabolism and drug development.

Prof. Fabrizio Andreelli

Institut Cochin, INSERM Unit 1016, Paris, France

Prof. Cliff Bailey

Head of Diabetes Research and Professor of Clinical Science
Aston University, Birmingham, England

Prof. Gerd Bode

Expert in Toxicology, Goettingen, Germany
European Industry (EFPIA) ICH-Topic Leader for Preclinical Safety Guidelines from 1989 to 2005 in the International Conferences on Harmonisation

Prof. Michaela Diamant

Department of Endocrinology, Diabetes Center, VU University Medical Center, Amsterdam, The Netherlands

Prof. Silvio E. Inzucchi

Professor of Medicine (Endocrinology), Clinical Director, Section of Endocrinology, Yale School of Medicine, New Haven, USA

Dr. Jean-Louis Junien

Expert in Pharmaceutical Development, Paris, France
Former Vice-President R&D at Fournier Pharmaceuticals

Prof. Harold Lebovitz

Professor of Medicine in the Division of Endocrinology and Metabolism/Diabetes
State University of NY, Health Sciences Center, Brooklyn, USA

Prof. Guntram Schernthaner

Head of the Department of Medicine 1, Rudolfstiftung Hospital, Vienna, Austria

Sitemap | Legal
© Poxel SA